Patient-Centered Value Assessment of Multiple Sclerosis Treatments - Surachat Ngorsuraches, PhD & Natasha Frost, MD

Intended Audience

MD, medical students, PhD (faculty, post-docs) graduate students, Researchers and Scientists, MDPhDs, DO, NPs, PAs, RN, APRN, Psychologists, Faculty and resident specialties including neurology (adult and pediatric neurology, neuropsychology), neurosurgery, neuroradiology, interventional neuroradiology, developmental pediatrics.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • To define the attributes of disease-modifying therapies (DMTs) that are important to patients with MS.
  • To identify factors influencing patients’ willingness-to-pay (WTP) for DMTs.
  • To examine discrete choice experiment (DCE) as a patient-centered value assessment method.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Registration opens: 
12/13/2021
Course expires: 
12/12/2022
Cost:
$0.00
Rating: 
0

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

For this accredited continuing educational activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:


Click here to view the Planning Committee Disclosures (2020-21)
Click here to view the Planning Committee Disclosures (2021-22)

Discloser List CME Internal Report

Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Designation Statements

American Medical Association

The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Units

The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .1 continuing education units (CEUs) or 1 hour.

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Cost:
$0.00
Please login or register to take this course.

QUESTIONS ABOUT REGISTRATION

Email help@icep.wisc.edu

ACCESSIBILITY

The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu

Required Hardware/software

Computer, tablet, or other mobile device with sound.

Free, current version of Edge, Firefox, Safari, or Chrome. Some older browsers and Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader.